tetraethylammonium has been researched along with Long QT Syndrome in 2 studies
Tetraethylammonium: A potassium-selective ion channel blocker. (From J Gen Phys 1994;104(1):173-90)
Long QT Syndrome: A condition that is characterized by episodes of fainting (SYNCOPE) and varying degree of ventricular arrhythmia as indicated by the prolonged QT interval. The inherited forms are caused by mutation of genes encoding cardiac ion channel proteins. The two major forms are ROMANO-WARD SYNDROME and JERVELL-LANGE NIELSEN SYNDROME.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jow, F | 1 |
Tseng, E | 1 |
Maddox, T | 1 |
Shen, R | 1 |
Kowal, D | 1 |
Dunlop, J | 1 |
Mekonnen, B | 1 |
Wang, K | 1 |
Smith, PL | 1 |
Baukrowitz, T | 1 |
Yellen, G | 1 |
2 other studies available for tetraethylammonium and Long QT Syndrome
Article | Year |
---|---|
Rb+ efflux through functional activation of cardiac KCNQ1/minK channels by the benzodiazepine R-L3 (L-364,373).
Topics: Animals; Anthracenes; Benzodiazepines; CHO Cells; Chromans; Cricetinae; Cyclic Nucleotide-Gated Cati | 2006 |
The inward rectification mechanism of the HERG cardiac potassium channel.
Topics: Animals; Arrhythmias, Cardiac; Cation Transport Proteins; Cell Line; DNA-Binding Proteins; Drosophil | 1996 |